The Ablation of Sensory Neurons Expressing the Nav1.8 Sodium Channel Improves Glucose Homeostasis and Amplifies the GLP‐1 Signaling in Obese Female Mice
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Marina Romaní-Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Horizon 2020 research and innovation program, Marie Sklodowska-Curie, Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
Scope Sensory neurons expressing the sodium channel Nav1.8 contain a repertoire of receptors for nutrient, hormonal, and inflammatory ligands. However, their function in key regulators of energy homeostasis control is not well understood and is completely unexplored in females. Methods and results Mice lacking neurons expressing the sodium channel Nav1.8 were generated using an ablation strategy based on cre recombinase‐mediated expression of diphtheria toxin fragment A (DTA) (Nav1.8‐cre/DTA mice) to investigate whether these neurons modulate body weight, food intake, gut hormone secretion, gastrointestinal transit, and glucose tolerance in response to nutrient challenges in a sex‐dependent manner. Male Nav1.8‐cre/DTA mice show resistance to gain weight in response to high‐fat high‐sugar diet (HFHSD), whereas females lacking Nav1.8+ neurons have improved oral glucose tolerance accompanied by higher insulin levels and attenuated glucagon secretion after an oral glucose load. Female Nav1.8‐cre/DTA mice also show higher fasting and postprandial glucagon like peptide‐1 (GLP‐1) levels with an increased number of GLP‐1‐positive cells. Finally, ablation of Nav1.8‐expressing neurons accelerates the gastrointestinal transit in female mice under HFHSD. Conclusion This data demonstrates sex‐dependent differences in the Nav1.8‐mediated regulation of energy metabolism, and provides new insights that may help in the design of sex‐specific neuromodulation therapies for metabolic disorders induced by diets rich in fats and simple sugars.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain.
ORCID-Profile: Marina Romaní-Pérez, Clara Bullich-Vilarrubias, Inmaculada López-Almela, Yolanda Sanz
Förderung
- European Union Horizon 2020 research and innovation program
- Marie Sklodowska-Curie
- Spanish Ministry of Science and Innovation
- European Commission - NextGenerationEU
- CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGING+ (PTI-NEURO-AGING+)
- Accredited Centre of Excellence
- Ministerio de Ciencia e Innovación
Zitieren
APA
Romaní-Pérez, M., Bullich-Vilarrubias, C., López-Almela, I., & Sanz, Y. (2024). The Ablation of Sensory Neurons Expressing the Nav1.8 Sodium Channel Improves Glucose Homeostasis and Amplifies the GLP‐1 Signaling in Obese Female Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300474
Vancouver
Romaní-Pérez M, Bullich-Vilarrubias C, López-Almela I, Sanz Y. The Ablation of Sensory Neurons Expressing the Nav1.8 Sodium Channel Improves Glucose Homeostasis and Amplifies the GLP‐1 Signaling in Obese Female Mice. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300474
BibTeX
@article{RomanPrez2024,
author = {Romaní-Pérez, Marina and Bullich-Vilarrubias, Clara and López-Almela, Inmaculada and Sanz, Yolanda},
title = {The Ablation of Sensory Neurons Expressing the Nav1.8 Sodium Channel Improves Glucose Homeostasis and Amplifies the GLP‐1 Signaling in Obese Female Mice},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300474}
}
EUVIMED